|
Organized in association with UCD, this conference is designed to bring investigators from oncological backgrounds (both basic and
clinical) into close contact with equivalent leaders in proteomics approaches.
The aim is to create a translational framework by which proteomics investigations can advance our knowledge of cancer-related processes and ultimately be utilized in a clinical context.
The event will be held in the dynamic city of Dublin, economic and cultural centre of Ireland.
Register now and save up to €100!
Agenda Topics
- Trends in Proteome Diagnostics and Proteome Therapeutics
- Protein Biomarkers for Diagnostics
- Drug Targets
- Response Monitoring
Sponsorship and Exhibition Opportunities
paul.raggett@selectbiosciences.com
+44 (0) 1787 315117
|
|
Confirmed Speakers
Ruedi Aebersold Swiss Federal Institute of Technology
Rolf Apweiler European Bioinformatics Institute
Roz Banks St. James's University Hospital
Carl Borrebaeck Lund University
Dolores Cahill UCD Conway Institute
Richard Caprioli Vanderbilt University
Julio Celis Danish Centre for Translational Breast Cancer Research
Sam Hanash Fred Hutchinson Cancer Research Centre
Stephen Hewitt Advanced Technology Centre - National Cancer Institute
Hubert Hondermarck INSERM-University of Lille
Lukas Huber Biocenter of the Medical University Innsbruck
Elaine Kay Royal College of Surgeons in Ireland
Walter Kolch Cancer Research UK Beatson Laboratories
Bernhard Kuster Technical University of Munich
Hanno Langen F. Hoffmann-La Roche
Mark O’Connor KuDOS Pharmaceuticals
Peadar O’Gaora UCD Conway Institute
Renata Pasqualini M. D. Anderson Cancer Centre
Amanda Paulovich Fred Hutchinson Cancer Research Centre
Fredrik Ponten University of Uppsala
Steven Potts Aperio
John Quackenbush Dana-Farber Cancer Institute
Doug Ross Applied Genomics
Richard Simpson Ludwig Institute for Cancer Research, Royal Melbourne Hospital
Paul Tempst Memorial Sloan-Kettering Cancer Centre
Sara Zanivan Max Planck Institute for Biochemistry | |